Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
AJMB-Avicenna Journal of Medical Biotechnology. 2018; 10 (4): 242-247
em Inglês | IMEMR | ID: emr-203112

RESUMO

Background: Alzheimer's Disease [AD] is a neurodegenerative disorder, which is the most common cause of dementia in the elderly. Accumulation of beta-amyloid plaques outside neurons is the most important pathological hallmark of AD, which is produced by cleavage of amyloid precursor protein by the Alzheimer's beta-secretase [BACE1]. Since BACE1 is a key enzyme in the formation of beta-amyloid peptides, the purpose of this study was to assess the association between polymorphisms of G/C [rs638405] BACE1 gene with sporadic AD in Khuzestan, Isfahan and Fars provinces in Iran


Methods: Genotypes were determined by the PCR–Restriction Fragment Length Polymorphism [PCR–RFLP] technique in two groups including 89 sporadic AD patients and 73 healthy subjects


Results: The findings of the BACE1 G/C [rs638405] polymorphism revealed that there was no significant difference between AD patients and controls in men group; however, there was a weak difference in the frequency of CC genotype between patients and controls in women group [?2=3.333, df=1, p=0.068]


Conclusion: The results of this study suggest that the G/C [rs638405] polymorphism of BACE1 gene might not be related with sporadic AD in Khuzestan, Isfahan and Fars provinces in Iran. However, our results do not support a genetic risk factor of this polymorphism for developing AD in male group of this study

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA